Related references
Note: Only part of the references are listed.Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Hyeong Min Kim et al.
PHARMACEUTICS (2021)
Age-Related Macular Degeneration (AMD): A View to the Future
Joan W. Miller et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Aberrant Complement System Activation in Neurological Disorders
Karolina Ziabska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cell-Type-Specific Complement Expression in the Healthy and Diseased Retina
Diana Pauly et al.
CELL REPORTS (2019)
Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy
Kenneth J. Katschke et al.
SCIENTIFIC REPORTS (2018)
Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration
Haihan Jiao et al.
MOLECULAR NEURODEGENERATION (2018)
Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain
Maria I. Fonseca et al.
JOURNAL OF NEUROINFLAMMATION (2017)
The link between morphology and complement in ocular disease
Camilla Mohlin et al.
MOLECULAR IMMUNOLOGY (2017)
Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation
Hansen Lui et al.
CELL (2016)
C1q propagates microglial activation and neurodegeneration in the visual axis following retinal ischemia/reperfusion injury
Sean M. Silverman et al.
MOLECULAR NEURODEGENERATION (2016)
Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma
Pete A. Williams et al.
MOLECULAR NEURODEGENERATION (2016)
Schizophrenia risk from complex variation of complement component 4
Aswin Sekar et al.
NATURE (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
A Mechanistic Pharmacokinetic/Pharmacodynamic Model of Factor D Inhibition in Cynomolgus Monkeys by Lampalizumab for the Treatment of Geographic Atrophy
Kha N. Le et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 A Systematic Review and Meta-Analysis
Yih-Chung Tham et al.
OPHTHALMOLOGY (2014)
Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice
Gareth R. Howell et al.
JOURNAL OF NEUROINFLAMMATION (2013)
A Dramatic Increase of C1q Protein in the CNS during Normal Aging
Alexander H. Stephan et al.
JOURNAL OF NEUROSCIENCE (2013)
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Dorothy P. Schafer et al.
NEURON (2012)
Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma
Gareth R. Howell et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Complement and its role in innate and adaptive immune responses
Jason R. Dunkelberger et al.
CELL RESEARCH (2010)
Oxidative Stress and the Regulation of Complement Activation in Human Glaucoma
Guelguen Tezel et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Functional and Structural Changes in a Canine Model of Hereditary Primary Angle-Closure Glaucoma
Sinisa D. Grozdanic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions
Suzanne S. Bohlson et al.
MOLECULAR IMMUNOLOGY (2007)
Retinal synthesis and deposition of complement components induced by ocular hypertension
Markus H. Kuehn et al.
EXPERIMENTAL EYE RESEARCH (2006)
Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes
K Stasi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration
J Gaudreault et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Share Paper
